BSECompany Update23 Jul 2026 · 23 Jul 2026, 04:38 pm
Enclosed herewith press release for the order received from one of the leading FMCG Company
Veerhealth Care Ltd · 511523
✦ AI Summary▲ PositiveOrder Win
Veerhealth Care Ltd has received a new sample order worth ₹76.40 lakhs from a leading FMCG company for skincare products, with an expected execution period of 45 days. The company expects total income of ₹105 crores with a PAT of ₹5-6 crores in FY 2026-27 and ₹156 crores with a PAT of ₹9-10 crores in FY 2027-28.
Analysis Scores
Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attachments (1)
📄pdf
Download →
7dfddc37-16aa-4456-a763-9da9882b7a94.pdf
View document text
Veerhealth Carcz Ltd.
CIN: L65910MH1992PLC067632
Date: 23.07.2026
BSE Limited
Department of Corporate Services
P. J. Towers, Dalal Street,
Mumbai- 400001
Scrip C ode: 511523
Subject: Press Release on receipt of order
Dear Sir/Ma' am,
We are enclosing herewith the press release on receipt of New Sample order worth ~76.40 Iakhs
from one of India's leading FMCG company for Skincare products.
You are requested to take the same on record.
you.
Thanking
Yours faithfully
For V eerhealth Care limited
Bhavin S. Shah
Managing Director
DIN: 03129574
Reg. Off.: 629-A Gazdar House, I st Floor, Near Kalbadevi Post Office, J.S.S. Marg. Mumbai - 400 002.
Tel. No.: (022) 22018582 Fax No.: (022) 22072644 E-mail: info@veerhealthcare.net Website: www.veerhealthcare.net • www.ayuveer.com
Works : Plot No. 224, Vibrant Business Park, Opp UPL, National Highway No. 8, Vapi- 396191, Gujarat
Vaerl-faalth Carcz Ltd.
NATUR£-AL 011\ECTtON TO
Veerhealth Care received New Sample order worth t76.40 lakhs from one of India's
Leading FMCG company for Skin Care Products
Mumbai- 23rd July, 2026: Veerhealth Care Limited (BSE: VEERHEALTH), Veerhealth Care is
lndia's one of the fastest growing Listed Ayurvedic & Cosmetic formulation manufacturing company.
Ayuveer, backed by Veerhealth Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines
and personal care range of products. With a focus on quality and affordability, Ayuveer aims to offer an
exceptional and safe daily care experience to its customers.
This is a New Sample order from same Client for Supply of Skin Care Products. The order will be executed
within 45 days. Under this agreement, the Company will manufacture products which would be launched under
a new MRP structure specifically designed for brand promotion and market expansion.
The buyer is a Leading FMCG company which operates in the domestic and international markets in the 'personal
and household care' segment. This company is part of a 125 year old prominent Business Group.
In F. Y. 2026-27 we are expecting Total .Income 105 crores with PAT of minimum 5- 6 crores.
In F. Y. 2027-28 we are expecting Total Income of~ 156 crores with PAT of minimum ~ 9- 10 crores.
The Book Value per share for FY26 is { 1 1.46. With recently received preferential warrants monies
the Book Value per share will increase substantially.
Currently we are in advanced stages of talk with one of India's largest hotel amenities supplier having
Indo-Canadian joint venture.
Globally, very few small-cap companies have secured USFDA plant clearance, positioning Veerhealth
Care in a distinctive category.
Veerhealth Care Limited specializes in manufacturing of Pure Vegetarian toothpaste.
Disclaimer
Cettain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements
are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological
risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward
looking statements. The Company will not be in any way responsible for any action taken based on such statements and undertakes
no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.